The 20 Best Hereditary Neuroblastoma Doctors near Hackensack, NJ

Robert Alter is an Otolaryngologist in Hackensack, New Jersey. Dr. Alter is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

Derek Hanson is a Pediatrics provider in Hackensack, New Jersey. Dr. Hanson is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Glioma, Medulloblastoma, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Aspiration.

Barbara Spitzer is a Pediatric Hematologist Oncology provider in Hackensack, New Jersey. Dr. Spitzer is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), and Bone Marrow Transplant.

Burton Appel is a Pediatric Hematologist Oncology provider in Hackensack, New Jersey. Dr. Appel is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Bone Marrow Aspiration.

Antonio Fojo is an Internal Medicine provider in New York, New York. Dr. Fojo is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Neuroendocrine Tumor, Pheochromocytoma, Adrenal Cancer, and Adrenocortical Carcinoma. Dr. Fojo is currently accepting new patients.

Zoltan Antal is a Pediatric Endocrinologist in New York, New York. Dr. Antal is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Hereditary Neuroblastoma, Neurohypophyseal Diabetes Insipidus, Diabetes Insipidus (DI), and Malnutrition.

Alfred Gillio is a Hematologist and an Oncologist in Hackensack, New Jersey. Dr. Gillio is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Acute Megakaryoblastic Leukemia, Graft Versus Host Disease (GvHD), Ataxia-Pancytopenia Syndrome, and Shwachman-Diamond Syndrome.

Minaxi Jhawer is an Oncologist in Englewood, New Jersey. Dr. Jhawer is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Gastroesophageal Junction Cancer.

I am a pediatric oncologist who specializes in caring for children with solid tumors, especially neuroblastoma, Wilms' and other kidney tumors, and liver tumors such hepatoblastoma and hepatocellular carcinoma. I serve as chief of the Division of Hematology, Oncology and Stem Cell Transplantation at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital.I treat children of all ages, from infants to young adults. Some of the cancers I treat are rare (liver tumors account for one to two percent of childhood cancers), but they can be very complex and require a multidisciplinary approach so patients have the best outcomes. I enjoy working as part of a team of physicians, nurse practitioners, nurses, social workers, child life specialists, and other dedicated professionals who care deeply about our patients and provide care with compassion and comfort.I also conduct basic science research. The latest advances in tumor genetics and the design of innovative therapies make this a very exciting time for cancer research. My team and I have done extensive research on the genetics of hepatoblastoma. We have developed mouse models of this disease and are entering a new phase where we are offering a personalized/precision medicine approach to children with this disease. We are also identifying novel genes that specifically target neuroblastoma—information that may be used to create targeted therapies. Dr. Yamashiro is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Hepatoblastoma.

Alice Levine is an Endocrinologist in New York, New York. Dr. Levine is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Cushing's syndrome, Pheochromocytoma, Adrenal Gland Adenoma, and Ectopic Cushing's syndrome.

Laura Boucai is an Endocrinologist in New York, New York. Dr. Boucai is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Christopher Barker is a Radiation Oncologist in New York, New York. Dr. Barker is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Melanoma of the Eye, and Liver Embolization. Dr. Barker is currently accepting new patients.

Robert Young is a Neuroradiologist in New York, New York. Dr. Young is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Posterior Fossa Tumor, Astrocytoma, Brain Tumor, and Metastatic Brain Tumor.

Keyur Mehta is a Radiation Oncologist in Bronx, New York. Dr. Mehta is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Breast Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Anal Cancer, Laryngeal Cancer, Throat Cancer, and Cervical Cancer.

Justin Tang is a Radiation Oncologist in Bronx, New York. Dr. Tang is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Fibrolamellar Carcinoma, Familial Prostate Cancer, Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Jana Fox is a Radiation Oncologist in Bronx, New York. Dr. Fox is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Laryngeal Cancer, and Throat Cancer.

James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field. Dr. Garvin is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His top areas of expertise are Brain Stem Cancer, Medulloblastoma, Glioma, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant.

Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation.Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium. Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, and Acute Monoblastic Leukemia (AmoL).